Johnson & Johnson (JNJ)
248.99
+0.56
(+0.23%)
USD |
NYSE |
Mar 02, 10:15
Johnson & Johnson Research and Development Expense (Annual) : 14.83B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Gilead Sciences, Inc. | 5.688B |
| Eli Lilly & Co. | 13.34B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Moderna, Inc. | 2.917B |